Cardiovascular complications and outcomes among athletes with COVID-19 disease: a systematic review

Bandar Alosaimi1,1, Isamme AlFayyad2, Salman Alshuaibi3

  • 1Research Center, King Fahad Medical City, Riyadh, 11525, Saudi Arabia. balosaimi@kfmc.med.sa.

Insights

COVID-19 infection has a low prevalence of cardiovascular complications in athletes during short-term follow-up. Early cardiac assessment is crucial for safe return-to-play protocols in athletes post-COVID-19.

Area of Science:

  • Sports Medicine
  • Cardiology
  • Infectious Diseases

Background:

  • Emerging evidence on cardiovascular sequelae of COVID-19 necessitates further research for safe return-to-play guidelines.
  • Athletes are a unique population requiring specific considerations regarding post-COVID-19 cardiovascular health.

Purpose of the Study:

  • To systematically review the prevalence of cardiovascular complications in athletes following COVID-19 infection.
  • To explore outcomes, diagnostic approaches, and safe return-to-play strategies for athletes post-COVID-19.

Main Methods:

  • Systematic search of Medline, Cochrane Library, Ovid, Embase, and Scopus for quantitative studies on athletes post-COVID-19 infection.
  • Inclusion of peer-reviewed studies reporting cardiovascular complications and outcomes in athletes; exclusion of non-athletic studies, editorials, and guidelines.
  • Quality assessment using the Newcastle-Ottawa Scale.

Main Results:

  • 15 articles with 6229 athletes included; 1023 were elite or professional.
  • Prevalence: myocarditis (0.4%-15.4%), pericarditis (0.06%-2.2%), pericardial effusion (0.27%-58%).
  • Elevated troponin levels reported in 0.9%-6.9% of athletes in five studies.

Conclusions:

  • Low short-term prevalence of cardiovascular complications following COVID-19 infection in athletes.
  • Early recognition and continuous cardiac assessment are vital for preventing complications and ensuring safe return-to-play.
  • A stepwise evaluation approach, emphasizing imaging, is critical for diagnosis and risk assessment.
Abstract

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
1.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
25
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
61